SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Summit Technology (BEAM)
BEAM 25.02+5.2%3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tassi who wrote (1339)8/25/1999 9:11:00 AM
From: Scott L. Olson   of 1386
 
Addendum to msg #1342

Re: BEAM, KERA, VISX

By the way, regarding BOL possibly requiring additional FDA full board approval? Who cares!

BOL is the last on the block, and will never get the market share from BEAM or KERA. I have not talked to a Dr. who even mentioned BOL?s excimer laser.

KERA could continue far outpacing earnings expectations since their procedure is easier than lasik Also, any new Dr?s not on board yet, may wish to save about $450,000 by not buying BEAM or VISX laser and instead only spending about $50,000 on KERA training procedure (no big expensive laser required)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext